INVO Fertility (IVF) Revenue (2011 - 2026)

INVO Fertility (IVF) has 16 years of Revenue data on file, last reported at $2.0 million in Q1 2026.

• On a quarterly basis, Revenue rose 23.09% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $7.3 million, a 10.32% increase from a year earlier, with the FY2024 full-year figure at $6.5 million, up 116.25% from the prior year.
• Revenue for Q1 2026 stood at $2.0 million, up from $1.8 million in the prior quarter.
• Over the last five years, Revenue for IVF reached as high as $2.0 million in Q1 2026 and fell as low as $146135.0 in Q2 2022.
• Historically, Revenue has averaged $1.1 million across 5 years, with a median of $1.4 million in 2023.
• Across the five-year window, Revenue tumbled 90.88% in 2022 and surged 481.38% in 2024, its largest moves.
• Year by year, Revenue stood at $278142.0 in 2022, then soared by 396.78% to $1.4 million in 2023, then increased by 22.02% to $1.7 million in 2024, then rose by 4.22% to $1.8 million in 2025, then gained by 14.69% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $2.0 million in Q1 2026, $1.8 million in Q3 2025, and $1.9 million in Q2 2025.